Caffeoylquinic Acid-Rich Extract of Aster glehni F. Schmidt Ameliorates Nonalcoholic Fatty Liver through the Regulation of PPARδ and Adiponectin in ApoE KO Mice

Aster glehni is well known for its therapeutic properties. This study was performed to investigate the effects of A. glehni on nonalcoholic fatty liver disease (NAFLD) in atherosclerotic condition, by determining the levels of biomarkers related to lipid metabolism and inflammation in serum, liver,...

Full description

Saved in:
Bibliographic Details
Main Authors: Yong-Jik Lee, Yoo-Na Jang, Yoon-Mi Han, Hyun-Min Kim, Jong-Min Jeong, Min Jeoung Son, Chang Bae Jin, Hyoung Ja Kim, Hong Seog Seo
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:PPAR Research
Online Access:http://dx.doi.org/10.1155/2017/3912567
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849410120063123456
author Yong-Jik Lee
Yoo-Na Jang
Yoon-Mi Han
Hyun-Min Kim
Jong-Min Jeong
Min Jeoung Son
Chang Bae Jin
Hyoung Ja Kim
Hong Seog Seo
author_facet Yong-Jik Lee
Yoo-Na Jang
Yoon-Mi Han
Hyun-Min Kim
Jong-Min Jeong
Min Jeoung Son
Chang Bae Jin
Hyoung Ja Kim
Hong Seog Seo
author_sort Yong-Jik Lee
collection DOAJ
description Aster glehni is well known for its therapeutic properties. This study was performed to investigate the effects of A. glehni on nonalcoholic fatty liver disease (NAFLD) in atherosclerotic condition, by determining the levels of biomarkers related to lipid metabolism and inflammation in serum, liver, and adipose tissue. Body and abdominal adipose tissue weights and serum triglyceride level decreased in all groups treated with A. glehni. Serum adiponectin concentration and protein levels of peroxisome proliferator-activated receptor δ, 5′ adenosine monophosphate-activated protein kinase, acetyl-CoA carboxylase, superoxide dismutase, and PPARγ coactivator 1-alpha in liver tissues increased in the groups treated with A. glehni. Conversely, protein levels of ATP citrate lyase, fatty acid synthase, tumor necrosis factor α, and 3-hydroxy-3-methylglutaryl-CoA reductase and the concentrations of interleukin 6 and reactive oxygen species decreased upon A. glehni. Triglyceride concentration in the liver was lower in mice treated with A. glehni than in control mice. Lipid accumulation in HepG2 and 3T3-L1 cells decreased upon A. glehni treatment; this effect was suppressed in the presence of the PPARδ antagonist, GSK0660. Our findings suggest that A. glehni extracts may ameliorate NAFLD through regulation of PPARδ, adiponectin, and the related subgenes.
format Article
id doaj-art-807c8f89be494c21be51b2ffa345ee70
institution Kabale University
issn 1687-4757
1687-4765
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series PPAR Research
spelling doaj-art-807c8f89be494c21be51b2ffa345ee702025-08-20T03:35:15ZengWileyPPAR Research1687-47571687-47652017-01-01201710.1155/2017/39125673912567Caffeoylquinic Acid-Rich Extract of Aster glehni F. Schmidt Ameliorates Nonalcoholic Fatty Liver through the Regulation of PPARδ and Adiponectin in ApoE KO MiceYong-Jik Lee0Yoo-Na Jang1Yoon-Mi Han2Hyun-Min Kim3Jong-Min Jeong4Min Jeoung Son5Chang Bae Jin6Hyoung Ja Kim7Hong Seog Seo8Cardiovascular Center, Korea University, Guro Hospital, 148 Gurodong-ro, Guro-gu, Seoul 08308, Republic of KoreaCardiovascular Center, Korea University, Guro Hospital, 148 Gurodong-ro, Guro-gu, Seoul 08308, Republic of KoreaCardiovascular Center, Korea University, Guro Hospital, 148 Gurodong-ro, Guro-gu, Seoul 08308, Republic of KoreaCardiovascular Center, Korea University, Guro Hospital, 148 Gurodong-ro, Guro-gu, Seoul 08308, Republic of KoreaCardiovascular Center, Korea University, Guro Hospital, 148 Gurodong-ro, Guro-gu, Seoul 08308, Republic of KoreaMolecular Recognition Research Center, Materials and Life Science Research Division, Korea Institute of Science and Technology, Hwarangno 14 Gil 5, Seoul 136-791, Republic of KoreaMolecular Recognition Research Center, Materials and Life Science Research Division, Korea Institute of Science and Technology, Hwarangno 14 Gil 5, Seoul 136-791, Republic of KoreaMolecular Recognition Research Center, Materials and Life Science Research Division, Korea Institute of Science and Technology, Hwarangno 14 Gil 5, Seoul 136-791, Republic of KoreaCardiovascular Center, Korea University, Guro Hospital, 148 Gurodong-ro, Guro-gu, Seoul 08308, Republic of KoreaAster glehni is well known for its therapeutic properties. This study was performed to investigate the effects of A. glehni on nonalcoholic fatty liver disease (NAFLD) in atherosclerotic condition, by determining the levels of biomarkers related to lipid metabolism and inflammation in serum, liver, and adipose tissue. Body and abdominal adipose tissue weights and serum triglyceride level decreased in all groups treated with A. glehni. Serum adiponectin concentration and protein levels of peroxisome proliferator-activated receptor δ, 5′ adenosine monophosphate-activated protein kinase, acetyl-CoA carboxylase, superoxide dismutase, and PPARγ coactivator 1-alpha in liver tissues increased in the groups treated with A. glehni. Conversely, protein levels of ATP citrate lyase, fatty acid synthase, tumor necrosis factor α, and 3-hydroxy-3-methylglutaryl-CoA reductase and the concentrations of interleukin 6 and reactive oxygen species decreased upon A. glehni. Triglyceride concentration in the liver was lower in mice treated with A. glehni than in control mice. Lipid accumulation in HepG2 and 3T3-L1 cells decreased upon A. glehni treatment; this effect was suppressed in the presence of the PPARδ antagonist, GSK0660. Our findings suggest that A. glehni extracts may ameliorate NAFLD through regulation of PPARδ, adiponectin, and the related subgenes.http://dx.doi.org/10.1155/2017/3912567
spellingShingle Yong-Jik Lee
Yoo-Na Jang
Yoon-Mi Han
Hyun-Min Kim
Jong-Min Jeong
Min Jeoung Son
Chang Bae Jin
Hyoung Ja Kim
Hong Seog Seo
Caffeoylquinic Acid-Rich Extract of Aster glehni F. Schmidt Ameliorates Nonalcoholic Fatty Liver through the Regulation of PPARδ and Adiponectin in ApoE KO Mice
PPAR Research
title Caffeoylquinic Acid-Rich Extract of Aster glehni F. Schmidt Ameliorates Nonalcoholic Fatty Liver through the Regulation of PPARδ and Adiponectin in ApoE KO Mice
title_full Caffeoylquinic Acid-Rich Extract of Aster glehni F. Schmidt Ameliorates Nonalcoholic Fatty Liver through the Regulation of PPARδ and Adiponectin in ApoE KO Mice
title_fullStr Caffeoylquinic Acid-Rich Extract of Aster glehni F. Schmidt Ameliorates Nonalcoholic Fatty Liver through the Regulation of PPARδ and Adiponectin in ApoE KO Mice
title_full_unstemmed Caffeoylquinic Acid-Rich Extract of Aster glehni F. Schmidt Ameliorates Nonalcoholic Fatty Liver through the Regulation of PPARδ and Adiponectin in ApoE KO Mice
title_short Caffeoylquinic Acid-Rich Extract of Aster glehni F. Schmidt Ameliorates Nonalcoholic Fatty Liver through the Regulation of PPARδ and Adiponectin in ApoE KO Mice
title_sort caffeoylquinic acid rich extract of aster glehni f schmidt ameliorates nonalcoholic fatty liver through the regulation of pparδ and adiponectin in apoe ko mice
url http://dx.doi.org/10.1155/2017/3912567
work_keys_str_mv AT yongjiklee caffeoylquinicacidrichextractofasterglehnifschmidtamelioratesnonalcoholicfattyliverthroughtheregulationofppardandadiponectininapoekomice
AT yoonajang caffeoylquinicacidrichextractofasterglehnifschmidtamelioratesnonalcoholicfattyliverthroughtheregulationofppardandadiponectininapoekomice
AT yoonmihan caffeoylquinicacidrichextractofasterglehnifschmidtamelioratesnonalcoholicfattyliverthroughtheregulationofppardandadiponectininapoekomice
AT hyunminkim caffeoylquinicacidrichextractofasterglehnifschmidtamelioratesnonalcoholicfattyliverthroughtheregulationofppardandadiponectininapoekomice
AT jongminjeong caffeoylquinicacidrichextractofasterglehnifschmidtamelioratesnonalcoholicfattyliverthroughtheregulationofppardandadiponectininapoekomice
AT minjeoungson caffeoylquinicacidrichextractofasterglehnifschmidtamelioratesnonalcoholicfattyliverthroughtheregulationofppardandadiponectininapoekomice
AT changbaejin caffeoylquinicacidrichextractofasterglehnifschmidtamelioratesnonalcoholicfattyliverthroughtheregulationofppardandadiponectininapoekomice
AT hyoungjakim caffeoylquinicacidrichextractofasterglehnifschmidtamelioratesnonalcoholicfattyliverthroughtheregulationofppardandadiponectininapoekomice
AT hongseogseo caffeoylquinicacidrichextractofasterglehnifschmidtamelioratesnonalcoholicfattyliverthroughtheregulationofppardandadiponectininapoekomice